Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.

Diğer sürümleri göster (1)

BACKGROUND: Maternal antibodies give neonates some protection against bacterial infection. We measured antibodies against Neisseria meningitidis serogroups A, C, Y and W135 in mothers and their 2-month-old infants at study enrollment. We also assessed the impact of maternal antibody present at 2 mo...

Detaylı Bibliyografya
Asıl Yazarlar:	Blanchard-Rohner, G, Snape, MD, Kelly, D, O'Connor, D, John, T, Kibwana, E, Parks, H, Ford, K, Dull, P, Pollard, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Benzer Materyaller

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis serogroups A, C, y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom
Yazar:: Blanchard-Rohner, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children
Yazar:: Marzia Monica Giuliani, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.
Yazar:: Blanchard-Rohner, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age
Yazar:: Blanchard-Rohner, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Neisseria meningitidis Serogroup W135, China
Yazar:: Zhujun Shao, ve diğerleri
Baskı/Yayın Bilgisi: (2010-02-01)

Pericarditis due to Neisseria meningitidis serogroup W135
Yazar:: Takashi Shinha, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Carriage of Neisseria meningitidis Serogroup W135 ST-2881
Yazar:: Pascal Boisier, ve diğerleri
Baskı/Yayın Bilgisi: (2006-09-01)

Hajj-Related Neisseria Meningitidis Serogroup W135 in Mauritius
Yazar:: Mohammad Iqbal Issack, ve diğerleri
Baskı/Yayın Bilgisi: (2002-03-01)

Increase in Neisseria meningitidis Serogroup W135, Niger, 2010
Yazar:: Jean-Marc Collard, ve diğerleri
Baskı/Yayın Bilgisi: (2010-09-01)

Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
Yazar:: Hoan Jong Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2014-11-01)

Travel-related Neisseria meningitidis Serogroup W135 Infection, France
Yazar:: Muhamed-Kheir Taha, ve diğerleri
Baskı/Yayın Bilgisi: (2013-06-01)

Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?
Yazar:: Katharina Schley, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
Yazar:: Lidia Serra, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Neisseria meningitidis Serogroup W135 Isolates Associated with the ET-37 Complex
Yazar:: Tanja Popovic, ve diğerleri
Baskı/Yayın Bilgisi: (2000-08-01)

Real-world impact and effectiveness of MenACWY-TT
Yazar:: Rodolfo Villena, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Towards an improved serogroup B Neisseria meningitidis vaccine.
Yazar:: Perrett, K, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
Yazar:: Khatami, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.
Yazar:: Khatami, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
Yazar:: Carr, JP, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.
Yazar:: Suzanne Chanteau, ve diğerleri
Baskı/Yayın Bilgisi: (2006-09-01)

Recent Increase in Meningitis Caused by Neisseria meningitidis Serogroups A and W135, Yaoundé, Cameroon
Yazar:: Marie-Christine Fonkoua, ve diğerleri
Baskı/Yayın Bilgisi: (2002-03-01)

Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile
Yazar:: María Gabriela Graña, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

A vaccine against serogroup B Neisseria meningitidis: Dealing with uncertainty
Yazar:: Andrews, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty.
Yazar:: Andrews, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.
Yazar:: Xie, O, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Neisseria meningitidis W135, Turkey
Yazar:: Levent Doganci, ve diğerleri
Baskı/Yayın Bilgisi: (2004-05-01)

Neisseria meningitidis Strain of Unknown Serogroup, China
Yazar:: Haijian Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2011-03-01)

Neisseria meningitidis Serogroup W135 Sequence Type 11, Anhui Province, China, 2011–2013
Yazar:: Shoukui Hu, ve diğerleri
Baskı/Yayın Bilgisi: (2014-07-01)

Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination
Yazar:: Cynthia Burman, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
Yazar:: Jacopo Enotarpi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
Yazar:: Timo Vesikari, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, Brazil
Yazar:: David E Barroso, ve diğerleri
Baskı/Yayın Bilgisi: (2007-09-01)

Characterization of Unusual Serogroups of <i>Neisseria meningitidis</i>
Yazar:: Samy Taha, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Serogroup A Neisseria meningitidis with Reduced Susceptibility to Ciprofloxacin
Yazar:: Jacob Strahilevitz, ve diğerleri
Baskı/Yayın Bilgisi: (2008-10-01)

The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.
Yazar:: Valerian B Pinto, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Neisseria meningitidis Serogroup W, Burkina Faso, 2012
Yazar:: Jessica R. MacNeil, ve diğerleri
Baskı/Yayın Bilgisi: (2014-03-01)

Spread of Neisseria meningitidis Serogroup W Clone, China
Yazar:: Haijian Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2013-09-01)

Neisseria meningitidis Serogroup X in Sub-Saharan Africa
Yazar:: Alain Agnememel, ve diğerleri
Baskı/Yayın Bilgisi: (2016-04-01)

Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.
Yazar:: Ivano de Filippis, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study
Yazar:: J. M. Kemmeren, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)